Código QR (código de barras bidimensional)

Efficacy of disitamab vedotin in non-small cell lung cancer with HER2 alterations: a multicenter, retrospective real-world study

BackgroundNon-small cell lung cancer (NSCLC) with human epidermal growth factor receptor 2 (HER2) alterations poses a substantial treatment challenge. Current HER2-targeted therapies offer limited efficacy. Antibody-drug conjugates (ADCs) targeting HER2 have emerged as a promising therapeutic strate...

ver descrição completa

Na minha lista:
Principais autores: Meiling Zhang, Li Wang, Qian Wang, Jiu Yang, Wei Peng, Xiaoyou Li, Meiqi Shi, Kaihua Lu
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2024-11-01
coleção:Frontiers in Oncology
Assuntos:
HER2 mutation
HER2 amplification
target
non-small cell lung cancer
RC48
Acesso em linha:https://www.frontiersin.org/articles/10.3389/fonc.2024.1441025/full
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registros relacionados